California Specialty Pharmacy Inc.

FDA inspection history in Whittier, California, 2019 to 2020

1
Untitled letter
1
Form 483

Every document, by year

  • Untitled letter
  • Form 483

2019: one Form 483; 2020: one untitled letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019–20One Form 483 and one untitled letter, at Whittier, California.

Cited most

Across all California Specialty Pharmacy observations on file

  • 21 CFR 211.67
    Equipment cleaning and maintenance
    1
  • 21 CFR 211.84
    Testing and approval or rejection of components, drug product containers, and closures
    1

The complete California Specialty Pharmacy file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2020-05-20Untitled letter Untitled letter$99
2019-05-17483 Form 483$99

Investigators on these documents

Stephanie A. Slater (1)

FEI number 3015131323 · most recent document May 20, 2020

About California Specialty Pharmacy Inc.

How many FDA Form 483s has California Specialty Pharmacy Inc. received?

FDA Intel has 1 Form 483 on file for California Specialty Pharmacy Inc.; the most recent is dated May 17, 2019.

When was California Specialty Pharmacy Inc. last inspected by FDA?

The most recent FDA inspection document on file for California Specialty Pharmacy Inc. is a Form 483 dated May 17, 2019, for the site in Whittier, California.

What did FDA cite at California Specialty Pharmacy Inc.?

The regulations cited most in the observations on file for California Specialty Pharmacy Inc. are 21 CFR 211.67 (Equipment cleaning and maintenance), 1 time; 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 1 time.

Has California Specialty Pharmacy Inc. received an FDA untitled letter?

Yes. FDA Intel has 1 FDA untitled letter on file for California Specialty Pharmacy Inc.; the most recent is dated May 20, 2020. An untitled letter is FDA's enforcement letter for violations that don't rise to warning-letter level.